J&J | JNJ - Sales Revenues

Johnson & Johnson reported $23.71B in Sales Revenues for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbott ABT:US USD 10.09B 319M
Abbvie ABBV:US USD 15.12B 309M
Amgen AMGN:US USD 6.84B 187M
AstraZeneca AZN:LN USD 11.21B 225M
Astrazeneca AZN:US USD 11.21B 225M
Baxter International BAX:US USD 3.89B 114M
Becton, Dickinson and BDX:US USD 4.59B 175M
Biogen BIIB:US USD 2.54B 35.5M
Boston Scientific BSX:US USD 3.24B 72M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Cardiovascular Systems CSII:US USD 61.45M 1.78M
Conmed CNMD:US USD 250.87M 24.22M
Dexcom DXCM:US USD 815.2M 45.6M
Edwards Lifesciences EW:US USD 1.35B 29.3M
Eli Lilly And LLY:US USD 7.3B 360.2M
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Hologic HOLX:US USD 1.07B 121M
Intuitive Surgical ISRG:US USD 1.66B 97.6M
Johnson & Johnson JNJ:US USD 23.71B 85M
Merk MRK:US USD 13.83B 1.13B
Novartis NOVN:VX USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Stryker SYK:US USD 5.2B 723M
Teva Pharmaceutical TEVA:IT USD 3.88B 289M
Vertex Pharmaceuticals VRTX:US USD 2.3B 31.6M
Zimmer Biomet Holdings Inc ZBH:US USD 1.83B 155.3M
Zoetis ZTS:US USD 2.04B 38M